BDSX (Biodesix) Bathi resik saben saham (EPS TTM)

BDSX (Biodesix Corp) - tandha merek perusahaan

Biodesix, Inc. (BDSX) leads in comprehensive lung cancer diagnostics, leveraging AI for accelerated biomarker analysis. Net income per share over the last 12 months illustrates profit dynamics, where the -2.78 metric confirms the current level. Biodesix, Inc. (BDSX) implements tests through partnerships with clinics and pharmaceutical behemoths. A wide range of rapid diagnostics and insurance coverage enable the company to effectively expand its market share.

BDSX Bathi saben saham sajrone rolas wulan pungkasan biodesix.com (04.07.2022 - 15.11.2026)

Rincian metrik lan analitis perusahaan Biodesix Corp (BDSX)

- kuotasi saiki lan rata-rata prakiraan nilai:
Bagan rega Biodesix Corp|BDSX - Prakiraan gabungan firma investasi
- indikator valuasi pasar bisnis:
Kapitalisasi pasar Biodesix Inc|BDSX - Nilai Perusahaan
- rincian valuasi buku bisnis:
Aset Bersih saben Siji Saham Biodesix|BDSX - Nilai Buku Perusahaan|Rasio Kapitalisasi marang Aset Bersih biodesix.com|BDSX - Aset Perusahaan
- data tingkat utang lan likuiditas finansial:
Utang marang Ekuitas Biodesix, Inc.|BDSX - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang modal biodesix.com|BDSX - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Biodesix|BDSX - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Biodesix|Rasio cepet biodesix.com
- data bathi lan kelipatan valuasi:
BDSX - Asil keuangan resik|Bathi sing dikarepake Biodesix, Inc.|BDSX - Kapitalisasi marang bathi|Pangali Forward P/E Biodesix, Inc.|BDSX - Rasio P/E diaturake wutah|Pangali EV/EBITDA Biodesix, Inc.|BDSX - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Biodesix|BDSX - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan biodesix.com|BDSX - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep Biodesix, Inc.
- indikator dodolan lan pendapatan:
BDSX - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Biodesix|BDSX - Rasio kapitalisasi pasar marang pendapatan|Multiplikator Forward P/S Biodesix
Analisis fundamental perusahaan:BDSX - Biodesix Inc
Produk seri Biodesix Inc

The market assesses the potential of Biodesix, Inc. (BDSX) through the lens of the scalability of its diagnostic solutions. The EPS TTM metric measures the portion of net income attributable to each share over a year, excluding the impact of the total issuance volume. By analyzing this chart of net income per share over the last 12 months, an investor can see the real profitability of the business. Growth in this metric directly depends on the expansion of Medicare insurance coverage and the integration of tests into clinics. This asset belongs to the high-tech biomedical sector.

Pesaing Biodesix, Inc.

carislifesciences.com - Bathi resik saben saham (EPS TTM)|GH: Bathi saben saham sajrone rolas wulan pungkasan|VCYT: Bathi resik saben saham (EPS TTM)|Celcuity Therapeutics (CELC) - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone rolas wulan pungkasan GRAIL, Inc.|Bathi saben saham sajrone rolas wulan pungkasan MYGN|Bathi resik saben saham sajrone 12 wulan pungkasan CSTL (Castle Bio)|Bathi resik saben saham sajrone patang kuartal pungkasan Burning Rock|Bathi saben saham sajrone rolas wulan pungkasan volition.com VNRX|Bathi resik saben saham sajrone patang kuartal pungkasan Precipio, Inc (PRPO)|Check-Cap Ltd - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone patang kuartal pungkasan mainzbiomed.com MYNZ|OncoCyte Inc (OCX) - Bathi saben saham sajrone rolas wulan pungkasan